-transparent.png){kind=logo}
Changes in cardiac gene expression were studied during development and regression of cardiac hypertrophy in spontaneously hypertensive rats (SHR) in an attempt to determine some of the biochemical factors responsible for alterations in cardiac mass. Chronic nifedipine treatment of SHR (30 mg/kg per day for 20 weeks) led to a marked reduction in arterial blood pressure and to a subsequent regression of cardiac hypertrophy. Cardiac mRNA concentration decreased, whereas cardiac protein concentration remained unchanged. Changes in cardiac gene expression, as reflected by the decrease in cardiac mRNA concentration, were thus identified as a major factor responsible for the regression of cardiac hypertrophy after nifedipine therapy of SHR.
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
January 1987,
Journal of cardiovascular pharmacology,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
January 1985,
Zeitschrift fur Kardiologie,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
January 1985,
Journal of cardiovascular pharmacology,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
January 1950,
Surgical forum,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
September 2001,
Circulation,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
August 1992,
The American journal of cardiology,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
April 1994,
Circulation research,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
January 1992,
Trends in cardiovascular medicine,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
November 1998,
Nature medicine,
J Zähringer, and
E Stangl, and
B Danninger, and
W Aschauer, and
W Motz, and
B E Strauer
August 1988,
Journal of molecular and cellular cardiology,
